At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antihypertensives
- Mechanism of Action Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
Most Recent Events
- 26 Feb 2001 Profile reviewed but not significant changes made
- 09 Jun 1997 No-Development-Reported for Hypertension in United Kingdom (PO)